CTOR
Price
$1.12
Change
-$0.10 (-8.20%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
101.89M
Intraday BUY SELL Signals
UTHR
Price
$484.43
Change
+$3.47 (+0.72%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
20.71B
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTOR vs UTHR

Header iconCTOR vs UTHR Comparison
Open Charts CTOR vs UTHRBanner chart's image
Citius Oncology
Price$1.12
Change-$0.10 (-8.20%)
Volume$3.95K
Capitalization101.89M
United Therapeutics
Price$484.43
Change+$3.47 (+0.72%)
Volume$5.85K
Capitalization20.71B
CTOR vs UTHR Comparison Chart in %
CTOR
Daily Signal:
Gain/Loss:
UTHR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CTOR vs. UTHR commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTOR is a Hold and UTHR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (CTOR: $1.22 vs. UTHR: $480.96)
Brand notoriety: CTOR and UTHR are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CTOR: 126% vs. UTHR: 52%
Market capitalization -- CTOR: $101.89M vs. UTHR: $20.71B
CTOR [@Pharmaceuticals: Generic] is valued at $101.89M. UTHR’s [@Pharmaceuticals: Generic] market capitalization is $20.71B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTOR’s FA Score shows that 0 FA rating(s) are green whileUTHR’s FA Score has 2 green FA rating(s).

  • CTOR’s FA Score: 0 green, 5 red.
  • UTHR’s FA Score: 2 green, 3 red.
According to our system of comparison, UTHR is a better buy in the long-term than CTOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTOR’s TA Score shows that 3 TA indicator(s) are bullish while UTHR’s TA Score has 3 bullish TA indicator(s).

  • CTOR’s TA Score: 3 bullish, 6 bearish.
  • UTHR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, UTHR is a better buy in the short-term than CTOR.

Price Growth

CTOR (@Pharmaceuticals: Generic) experienced а -3.17% price change this week, while UTHR (@Pharmaceuticals: Generic) price change was -1.53% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.75%. For the same industry, the average monthly price growth was +0.65%, and the average quarterly price growth was +19.08%.

Reported Earning Dates

UTHR is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.75% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($20.7B) has a higher market cap than CTOR($102M). UTHR YTD gains are higher at: 36.311 vs. CTOR (6.087). UTHR has higher annual earnings (EBITDA): 1.73B vs. CTOR (-25.48M). UTHR has more cash in the bank: 3.05B vs. CTOR (112). CTOR has less debt than UTHR: CTOR (3.8M) vs UTHR (200M). UTHR has higher revenues than CTOR: UTHR (3.08B) vs CTOR (0).
CTORUTHRCTOR / UTHR
Capitalization102M20.7B0%
EBITDA-25.48M1.73B-1%
Gain YTD6.08736.31117%
P/E RatioN/A18.23-
Revenue03.08B-
Total Cash1123.05B0%
Total Debt3.8M200M2%
FUNDAMENTALS RATINGS
UTHR: Fundamental Ratings
UTHR
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
15
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
28
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTORUTHR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
54%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
31%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 7 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
36%
Bearish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
41%
Bearish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 9 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 15 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
33%
Bearish Trend 7 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
CTOR
Daily Signal:
Gain/Loss:
UTHR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMQFF0.280.01
+2.58%
ABITIBI METALS CORP.
JTEKF8.42N/A
N/A
JTEKT Corp.
PPCLY0.59N/A
N/A
PPC Limited
KNRRY25.62-0.47
-1.82%
Knorr-Bremse
UTRX0.03N/A
-11.10%
Unitronix Corp.

CTOR and

Correlation & Price change

A.I.dvisor tells us that CTOR and HIMS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTOR and HIMS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTOR
1D Price
Change %
CTOR100%
-6.15%
HIMS - CTOR
21%
Poorly correlated
+2.09%
SILFF - CTOR
20%
Poorly correlated
N/A
TKNO - CTOR
14%
Poorly correlated
+8.82%
UTHR - CTOR
9%
Poorly correlated
+1.44%
RDHL - CTOR
7%
Poorly correlated
-1.68%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with MNKD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then MNKD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
+1.44%
MNKD - UTHR
38%
Loosely correlated
N/A
GERN - UTHR
37%
Loosely correlated
+3.25%
DAWN - UTHR
37%
Loosely correlated
-1.42%
ALNY - UTHR
36%
Loosely correlated
+1.80%
CBIO - UTHR
36%
Loosely correlated
+2.44%
More